Three-dimensional modeling of and ligand docking to vitamin D receptor ligand binding domain
- 4 February 2000
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 97 (4) , 1467-1472
- https://doi.org/10.1073/pnas.020522697
Abstract
The ligand binding domain of the human vitamin D receptor (VDR) was modeled based on the crystal structure of the retinoic acid receptor. The ligand binding pocket of our VDR model is spacious at the helix 11 site and confined at the β-turn site. The ligand 1α,25-dihydroxyvitamin D 3 was assumed to be anchored in the ligand binding pocket with its side chain heading to helix 11 (site 2) and the A-ring toward the β-turn (site 1). Three residues forming hydrogen bonds with the functionally important 1α- and 25-hydroxyl groups of 1α,25-dihydroxyvitamin D 3 were identified and confirmed by mutational analysis: the 1α-hydroxyl group is forming pincer-type hydrogen bonds with S237 and R274 and the 25-hydroxyl group is interacting with H397. Docking potential for various ligands to the VDR model was examined, and the results are in good agreement with our previous three-dimensional structure-function theory.Keywords
This publication has 34 references indexed in Scilit:
- Structure and specificity of nuclear receptor–coactivator interactionsGenes & Development, 1998
- New 1α,25-Dihydroxy-19-norvitamin D3 Compounds of High Biological Activity: Synthesis and Biological Evaluation of 2-Hydroxymethyl, 2-Methyl, and 2-Methylene AnaloguesJournal of Medicinal Chemistry, 1998
- Conformation−Function Relationship of Vitamin D: Conformational Analysis Predicts Potential Side-Chain StructureJournal of Medicinal Chemistry, 1998
- A canonical structure for the ligand-binding domain of nuclear receptorsNature Structural & Molecular Biology, 1996
- Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acidNature, 1995
- A structural role for hormone in the thyroid hormone receptorNature, 1995
- On the side chain conformation of 1α,25-dihydroxyvitamin D3 responsible for binding to the receptorBioorganic & Medicinal Chemistry Letters, 1995
- Syntheses of 1-Alkyl-1,25-dihydroxyvitamin D3The Journal of Organic Chemistry, 1995
- Two mutations in the hormone binding domain of the vitamin D receptor cause tissue resistance to 1,25 dihydroxyvitamin D3.Journal of Clinical Investigation, 1993
- Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptorsCell, 1991